Ibogaine Push for PTSD and Addiction | Cincinnati News

Bryan Hubbard is spearheading a bold push to get ibogaine—once considered a psychedelic, now seen as a medical breakthrough—FDA-approved for PTSD and opioid addiction. Though the experience is physically grueling, it uniquely resets brain pathways for up to nine weeks, offering hope for lasting recovery. Despite serious cardiac risks, Hubbard’s momentum is unstoppable: he turned Kentucky’s stalled opioid fund proposal into Texas’ landmark $100M Ibogaine Initiative, signed by Governor Abbott. Even former President Trump backed his cause with an executive order. With 12 states poised to join a multi-state trial and major advocacy groups rallying behind him, Hubbard’s goal is clear: FDA approval within six years—and universal access through affordability. This isn’t just about science—it’s about saving lives. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/dd83dc786f5d47af